Skip to main content

Table 1 Baseline characteristics of patients

From: Risperidone long-acting injection in Schizophrenia Spectrum Illnesses compared to first generation depot antipsychotics in an outpatient setting in Canada

Characteristic

RLAI* (n = 70)

FGAI (n = 102)

P value

 Age (Years)

39.7

42.7

0.09

 Gender (n (%) male)

45 (64.3)

63 (61.8)

0.74

 Weight (Kg)

90.61

89.88

0.97

 Time since diagnosis (Years)

9.85

13.6

0.003

  1. *Abbreviations are; RLAI Risperidone long-acting injection, FGAI First generation antipsychotic injection.
  2. Weight based on data on 41 and 52 patients for RLAI and FGAI, respectively.